MT-TF
geneOn this page
Also known as trnF
Summary
MT-TF (mitochondrially encoded tRNA-Phe (UUU/C), HGNC:7481) is a mitochondrial tRNA gene on chromosome mitochondria.
Predicted to enable triplet codon-amino acid adaptor activity. Predicted to be involved in translation.
Source: NCBI Gene 4558 — RefSeq curated summary.
At a glance
- Gene type: non-coding (Mt_tRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7481 |
| Approved symbol | MT-TF |
| Name | mitochondrially encoded tRNA-Phe (UUU/C) |
| Location | mitochondria |
| Locus type | RNA, transfer |
| Status | Approved |
| Aliases | trnF |
| Ensembl gene | ENSG00000210049 |
| Ensembl biotype | Mt_tRNA |
| OMIM | 590070 |
| Entrez | 4558 |
| RNAcentral | URS00003E8921 — tRNA, 71 nt, 5 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 Mt_tRNA
ENST00000387314
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000387314 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001544501 | 577 | 647 |
Expression profiles
Bgee: expression breadth ubiquitous, 118 present calls, max score 99.72.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 418.5871 / max 21897.5002, expressed in 1827 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 194814 | 398.4252 | 1827 |
| 194815 | 20.1619 | 1696 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| prefrontal cortex | UBERON:0000451 | 99.72 | gold quality |
| amygdala | UBERON:0001876 | 99.65 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 99.62 | gold quality |
| putamen | UBERON:0001874 | 99.54 | gold quality |
| caudate nucleus | UBERON:0001873 | 99.53 | gold quality |
| nucleus accumbens | UBERON:0001882 | 99.53 | gold quality |
| substantia nigra | UBERON:0002038 | 99.52 | gold quality |
| Ammon’s horn | UBERON:0001954 | 99.49 | gold quality |
| frontal cortex | UBERON:0001870 | 99.44 | gold quality |
| right frontal lobe | UBERON:0002810 | 99.41 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 99.29 | gold quality |
| hypothalamus | UBERON:0001898 | 99.27 | gold quality |
| sural nerve | UBERON:0015488 | 99.17 | gold quality |
| apex of heart | UBERON:0002098 | 99.00 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 98.97 | gold quality |
| duodenum | UBERON:0002114 | 98.90 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.46 | gold quality |
| mucosa of stomach | UBERON:0001199 | 98.41 | gold quality |
| cerebral cortex | UBERON:0000956 | 98.23 | gold quality |
| kidney | UBERON:0002113 | 98.18 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 97.77 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 97.54 | gold quality |
| granulocyte | CL:0000094 | 97.50 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.29 | gold quality |
| brain | UBERON:0000955 | 97.14 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.91 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.48 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 96.25 | gold quality |
| rectum | UBERON:0001052 | 95.86 | gold quality |
| adrenal tissue | UBERON:0018303 | 95.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.41 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- We report a novel heteroplasmic T–>C mutation at nt position 582 within the mitochondrial tRNA(Phe) gene of a 70-year-old woman with mitochondrial myopathy; This adds to the previously described four pathogenic mutations in the tRNA(Phe) gene (PMID:14659412)
- role of the point mutation at position 616 in the MT-TF gene (T>C or T>G)in severe epilepsy (PMID:20142618)
- Optic neuropathy, cardiomyopathy, and cognitive disability was found in patients with a homozygous mutation in the nuclear MTO1 and a mitochondrial MT-TF variant. (PMID:26061759)
- This is the 18th MT-TF point mutation associated with a mitochondrial disorder. The onset and the severity of the disease, however, is unique in this case and broadens the clinical picture related to mutations of mitochondrial tRNA-Phe. (PMID:31009750)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): familial primary hypomagnesemia, interstitial nephritis, Leber hereditary optic neuropathy, MELAS syndrome, MERRF syndrome, nephropathy, chronic tubulointerstitial